Exercise as a therapy to complement chemotherapy has a positive effect on muscles, balance and tumour-related fatigue syndrome, researchers said.
Patients tolerate the therapy better and experience less disease recurrence (relapses) later on. This has already been substantiated by many studies in the past.
However, these examined patients in the early stages of their illness and did not differentiate between various types of tumour, they said.
The study from Goethe University Frankfurt and Agaplesion Markus Hospital in Germany shows that patients with an advanced gastrointestinal tumour can also profit from exercise therapy.
If they were unable to manage this, then they were allowed to shorten their training sessions on the basis of a standardised model.
"For some patients, it was difficult to carry out the walking or jogging program in accordance with the recommendations," said Katrin Stucher, from Goethe University Frankfurt.
"A frequent obstacle was the weather: either it was too cold, too hot or too wet. But the side effects of the chemotherapy, such as loss of sensation, weakness, exhaustion, infections or severe diarrhea, also often meant that they had to reduce or even discontinue the programme," said Stucher.
Muscle mass improved as did functional properties, such as balance, walking speed and leg strength. The study also showed first indications that the toxicity of the chemotherapy can be reduced through moderate activity.
This is important because it is especially due to severe toxic effects that patients with gastrointestinal cancer often have to reduce the dose or even discontinue the chemotherapy altogether.
"We believe that it will make sense in future to offer patients opportunities for physical exercise during chemotherapy," said Winfried Banzer, from Goethe University Frankfurt in Germany.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
